Skip to main content

Table 5 Disease-free survival in AML and ALL patients in relation to PIM 2 and NF κβ median expression

From: PIM2 and NF-κβ gene expression in a sample of AML and ALL Egyptian patients and its relevance to response to treatment

 

No.

CR no.

Relapse or no. of deaths

Cumulative survival at 3 months %

P value

AML patients group

 NF κβ gene median expression

  1.019low$

15

10

5

56.0

0.593

  1.019equal/high#

15

6

9

53.3

 

 PIM2 gene median expression

     

  1.398low$

14

11

3

85.7

0.042*

  1.398equal/high#16

1

8

6

37.5

 

ALL Patients group

NF κβ gen median expression

  0.303low$

14

9

5

64.3

0.678

  0.303equal/high#

14

10

4

71.4

 

 PIM2 gene median expression

     

  1.988low$

19

11

9

64.3

0.233

  1.988equal/high#

11

8

3

71.4

 
  1. *P value < 0.05 is considered significant
  2. $Median level of expression lower than 1.398
  3. #Median level of expression equal or higher than 1.398